William R. Enquist - 04 Jun 2021 Form 4 Insider Report for Ra Medical Systems, Inc. (VTAK)

Role: Director
Signature: /s/ Daniel Horwood, as Attorney-in-Fact
Issuer symbol: VTAK
Transactions as of: 04 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 08 Jun 2021, 20:02:14 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RMED	Common Stock	Award	$0	+4,000	+27%	$0.000000	18,766	04 Jun 2021	Direct	F1
holding	RMED	Common Stock						5,263	04 Jun 2021	See Footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the reporting person's continued service.
F2	Shares held of record by the Enquist Family Trust UAD 12/13/1990, for which the reporting person serves as trustee.

Content

Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the reporting person's continued service.

Shares held of record by the Enquist Family Trust UAD 12/13/1990, for which the reporting person serves as trustee.